Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michael Korenfeld"'
Autor:
Joseph Tauber, David Evans, Bruce Segal, Xiao-Yan Li, Wang Shen, Caroline Lu, Gary D. Novack, Marc Abrams, Robert Smyth-Medina, Parag Majmudar, Edward Holland, Louis Alpern, Joseph Martel, Emma Clay, Michael Korenfeld, John Goosey, Damien Goldberg, Sherif El-Harazi
Publikováno v:
The ocular surface.
Evaluate the initial ocular safety and tolerability and efficacy of VVN001 Ophthalmic Solution (VVN001), a small-molecule antagonist of lymphocyte function-associated antigen-1 (LFA-1), in subjects with dry eye disease (DED).This was a multi-center,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e81dd0a7e62c44290cf9b365896fde
https://pubmed.ncbi.nlm.nih.gov/36586669
https://pubmed.ncbi.nlm.nih.gov/36586669
Autor:
Michael Korenfeld, Joe Gira, Kevin Jong, Joseph Martel, Steven Vold, Tom Walters, Dale Usner, Eric Donnenfeld
Publikováno v:
Clinical therapeutics. 44(12)
The goal of this study was to compare topical dexamethasone 1.5% in a novel formulation (OCS-01) once daily and BID versus vehicle for the treatment of inflammation and pain after cataract surgery.This was a Phase II, double-masked, vehicle-controlle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192c4231eaa57265186356c3e532948e
https://pubmed.ncbi.nlm.nih.gov/36503736
https://pubmed.ncbi.nlm.nih.gov/36503736
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 36:75-87
Background: Iontophoresis is a noninvasive delivery system designed to overcome barriers to ocular penetration of topical ophthalmic medications by employing a low-amplitude electrical current to promote the migration of a charged drug substance acro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f93f03c16ea1f7ec95eb026b2e8a6d
https://doi.org/10.1089/jop.2019.0034
https://doi.org/10.1089/jop.2019.0034
Autor:
Michael Korenfeld
Publikováno v:
Narrative inquiry in bioethics. 11(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46a80e24690e4bf83ec83fdf455ef273
https://pubmed.ncbi.nlm.nih.gov/34334449
https://pubmed.ncbi.nlm.nih.gov/34334449
Autor:
Amy E, Cohen, Carol, Assang, Michael A, Patane, Stephen, From, Michael, Korenfeld, Charles G, Connor
Publikováno v:
Ophthalmology. 119(1)
Purpose Determine safe, effective, iontophoretic dose(s) of EGP-437 (dexamethasone phosphate formulated for iontophoresis) in patients with noninfectious anterior uveitis; evaluate systemic drug exposures. Design Prospective, phase I/II, multicenter,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea3a2048246b7226e1d51b7550e514b9
https://pubmed.ncbi.nlm.nih.gov/22115712
https://pubmed.ncbi.nlm.nih.gov/22115712